Clinical Trial Results: Interactive Walkway for Fall-Risk Biomarkers in the Elderly
Key Findings:
Study compared zolpidem and suvorexant in elderly subjects to assess the sensitivity of the Interactive Walkway (IWW) in measuring walking adaptability and fall risk.
Results indicated that zolpidem led to decreased performance in walking adaptability, Timed-Up-and-Go test, and body sway, while suvorexant had minimal impact on IWW measurements.
IWW successfully quantified the effects of the two drugs and showed sensitivity in assessing dynamic balance and potential fall risk in early clinical drug development.
Practical Solutions and Value:
Implementing AI-driven platforms like DocSym can consolidate clinical standards and research, making knowledge easily accessible for clinicians and enhancing treatment development.
Mobile apps supporting scheduling, treatment monitoring, and telemedicine can streamline operations, manage patient care, and expand services digitally in today’s healthcare environment.
AI can enhance clinic workflows, improve patient outcomes, and reduce routine paperwork, ultimately benefiting both healthcare providers and patients.
Learn more about how we can help at aidevmd.com.
